Alison W Rebman Selected Research

Antibodies

4/2024	Autoantibodies in post-treatment Lyme disease and association with clinical symptoms.
1/2024	Annexin A2 antibodies in post-treatment Lyme disease.
1/2022	Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease.
1/2020	Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease.
1/2018	Robust B Cell Responses Predict Rapid Resolution of Lyme Disease.
1/2017	The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.
12/2015	Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison W Rebman Research Topics

Disease

20	Lyme Disease (Disease, Lyme) 04/2024 - 01/2012
9	Post-Lyme Disease Syndrome 04/2024 - 12/2018
6	Erythema 01/2024 - 01/2012
5	Infections 04/2024 - 12/2015
2	Tick-Borne Diseases (Tick-Borne Disease) 12/2020 - 02/2016
2	Exanthema (Rash) 12/2020 - 08/2012
2	Pain (Aches) 01/2020 - 03/2017
2	Fatigue 01/2020 - 03/2017
1	COVID-19 04/2024
1	Bacterial Infections (Bacterial Infection) 11/2022
1	Inflammation (Inflammations) 01/2022
1	Multiple Sclerosis 01/2022
1	Neuromyelitis Optica (Devic's Disease) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Cognitive Dysfunction 03/2017
1	Chronic Disease (Chronic Diseases) 02/2016

Drug/Important Bio-Agent (IBA)

13	Anti-Bacterial Agents (Antibiotics)IBA 08/2023 - 01/2012
7	AntibodiesIBA 04/2024 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 02/2016
2	AutoantibodiesIBA 04/2024 - 01/2022
2	Doxycycline (Periostat)FDA LinkGeneric 01/2019 - 03/2015
2	AntigensIBA 01/2018 - 12/2015
2	Immunoglobulin G (IgG)IBA 12/2015 - 08/2012
1	Annexin A2 (Annexin II)IBA 01/2024
1	mirfentanilIBA 01/2022
1	Protein-Arginine DeiminasesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	VaccinesIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Blood Proteins (Serum Proteins)IBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 12/2018
1	ChemokinesIBA 09/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2015
1	Immunoglobulin M (IgM)IBA 12/2015
1	Peptides (Polypeptides)IBA 12/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2012

Therapy/Procedure

6	Aftercare (After-Treatment) 08/2023 - 02/2016
5	Therapeutics 01/2019 - 01/2012
2	Ambulatory Care (Outpatient Care) 08/2023 - 01/2020
2	Time-to-Treatment 01/2023 - 01/2020
1	Treatment Delay 01/2020